SANOFI SYNTHELABO
Sanofi-Synthelabo Inc., a pharmaceutical company, provides products for physicians and patients in the healthcare industry. It focuses on various therapeutic areas, such as cardiovascular diseases and thrombosis, diseases of the central nervous system, internal medicine, and oncology. The company was incorporated in 1989 and is headquartered in New York, New York. Sanofi-Synthelabo Inc. operates as a subsidiary of Sanofi. Source: {Businessweek} (http://investing.businessweek.com/research/stocks/private/snapshot.asp?privcapId=4205385)
SANOFI SYNTHELABO
Industry:
Health Care Pharmaceutical Therapeutics
Address:
New York, New York, United States
Country:
United States
Status:
Active
Contact:
800-981-2491
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Tag Manager Font Awesome Domain Not Resolving Nginx Euro Organization Schema IPv6 JsDelivr
Current Advisors List
More informations about "Sanofi Synthelabo"
A Leading Immunology Healthcare Company | Sanofi
Nov 27, 2024 Press Release: Jean-Paul Kress to join Sanofi's Board of Directors. Read the Press Release. December 17, 2024. Press Release: Duvakitug positive phase 2b results demonstrate best-in-class potential in …See details»
Our Company, pioneering pharmaceutical innovations | Sanofi
Sanofi, a global healthcare pharmaceutical company, is dedicated to improving lives through discovering, developing and delivering medicines and vaccines. Global pharmaceutical …See details»
The Sanofi-Synthélabo Group - Encyclopedia.com
Sanofi Group is formed as a subsidiary of Elf Aquitaine. 1981: Sanofi forms joint subsidiary with American Home Products. 1983: Sanofi opens biotechnology center in Lab è ge, France. …See details»
Where we are - Sanofi
Several other Sanofi Companies are operating worldwide to support our mission. Companies focused on Research and Development. The following companies are applying their specialized expertise to advance Sanofi’s Research and …See details»
Sanofi Pharmaceuticals - Healthcare Innovations
Oct 24, 2024 Sanofi employees are making a positive impact through volunteerism, charitable donations, and community partnerships. From supporting local families in need to inspiring the next generation of scientists, Sanofi is …See details»
A look back at Sanofi's merger with Synthélabo - PMLiVE
May 24, 2013 The Synthélabo deal took the pressure off, however, bolstering Sanofi’s sales and marketing activities and giving the company access to even more successful products, including Ambien (zolpidem) for insomnia. By 2000 …See details»
Sanofi - Statistics & Facts | Statista
Mar 5, 2024 The multinational pharmaceutical company Sanofi was created in 2004 by the merger of the two French companies Sanofi-Synthélabo and Aventis. Operating under the …See details»
Sanofi-Synthelabo Inc - Company Profile and News
Company profile page for Sanofi-Synthelabo Inc including stock price, company news, executives, board members, and contact informationSee details»
Organization | Sanofi-Synthelabo - Purdue University
Organization Overview. First Clinical Trial. 1999 NCT00224679. First Marketed Drug. 1999 doxercalciferol . First NDA Approval. 2001 fondaparinux ... Sanofi-Synthelabo | SANOFI …See details»
A history of Sanofi - pharmaphorum
2 days ago This month’s exploration into a pharmaceutical company’s history is the turn of French company Sanofi, which began over 100 years ago as a number of small companies. Sanofi is one of the ...See details»
Our Company - Sanofi U.S.
The Sanofi of today is built on a heritage of turning the impossible into the possible for people and communities around the globe. Our Legacy MAT-US-2400483-v1.0-01/2024See details»
The Socio-Political Economy of Pharmaceutical Mergers: A Case …
Dec 7, 2006 This article critically analyses the events leading up to the 2004 merger between the pharmaceutical companies Sanofi-Synthelabo and Aventis. It reveals the social, commercial …See details»
Sanofi-Synthelabo LLC Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Sanofi-Synthelabo LLC of Bridgewater, NJ. Get the latest business insights from Dun & Bradstreet.See details»
Meet Our Executive Leadership Team - Sanofi
Get to know the executive leaders at Sanofi who drive innovation, commitment, and success across our global healthcare endeavors. The Executive Committee of Sanofi, global …See details»
SANOFI-SYNTHELABO LIMITED overview - Find and update …
Mar 14, 2023 More for SANOFI-SYNTHELABO LIMITED (02536338) Registered office address 410 Thames Valley Park Drive, Reading, Berkshire, England, RG6 1PT . Company status …See details»
Apotex Inc. v. Sanofi-Synthelabo Canada Inc., 2008 SCC 61 ... - CanLII
Nov 6, 2008 Sanofi‑Synthelabo Canada Inc., Sanofi‑Synthelabo . and Minister of Health. Respondents ‑ and ‑ Canadian Generic Pharmaceutical Association, BIOTECanada and …See details»
SR-121463. Sanofi-Synthélabo - PubMed
Sanofi-Synthélabo (formerly Sanofi) is developing SR-121463, a vasopressin V, receptor antagonist, as a potential treatment for cardiovascular indications such as congestive heart …See details»